This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/520944-france-extra-covid-vaccine-dose-immunocompromised/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| French health chiefs recommend 3rd dose of Moderna, Pfizer Covid-19 vaccines for people with weakened immune systems | French health chiefs recommend 3rd dose of Moderna, Pfizer Covid-19 vaccines for people with weakened immune systems |
| (5 months later) | |
| People with weakened immune systems should receive three doses of the two main Covid-19 vaccines being used in France made by Pfizer-BioNTech and Moderna, the country’s top health officials have recommended. | People with weakened immune systems should receive three doses of the two main Covid-19 vaccines being used in France made by Pfizer-BioNTech and Moderna, the country’s top health officials have recommended. |
| “The injection of a third dose of mRNA vaccine is necessary for severely immunocompromised people,” the Directorate General of Health (DGS) said in a note sent out to health professionals on Sunday. | “The injection of a third dose of mRNA vaccine is necessary for severely immunocompromised people,” the Directorate General of Health (DGS) said in a note sent out to health professionals on Sunday. |
| This includes people who have undergone organ transplants or recent bone marrow transplants, as well as dialysis patients and those with autoimmune diseases who are under strong immunosuppressive treatments, BFMTV reported. | This includes people who have undergone organ transplants or recent bone marrow transplants, as well as dialysis patients and those with autoimmune diseases who are under strong immunosuppressive treatments, BFMTV reported. |
| The third dose must be administered four weeks after the second, or “as soon as possible” for people who have already exceeded this period, the DGS said. | The third dose must be administered four weeks after the second, or “as soon as possible” for people who have already exceeded this period, the DGS said. |
| Cancer patients, people with chronic kidney disease who aren’t on dialysis, and patients with autoimmune diseases who don’t take Anti-CD20 or antimetabolite drugs are not included in the new advisory, the DGS said. | Cancer patients, people with chronic kidney disease who aren’t on dialysis, and patients with autoimmune diseases who don’t take Anti-CD20 or antimetabolite drugs are not included in the new advisory, the DGS said. |
| The agency also said it would make further vaccine recommendations. | The agency also said it would make further vaccine recommendations. |
| The DGS’s decision is in response to an opinion published on April 6 by the government’s vaccine advisory council, which recommended a third dose for immunocompromised people. | The DGS’s decision is in response to an opinion published on April 6 by the government’s vaccine advisory council, which recommended a third dose for immunocompromised people. |
| Last month, a US study of 436 organ transplant recipients who took either the Moderna or Pfizer jabs showed that just 17% developed neutralizing antibodies within 20 days of vaccination. | Last month, a US study of 436 organ transplant recipients who took either the Moderna or Pfizer jabs showed that just 17% developed neutralizing antibodies within 20 days of vaccination. |
| The research, published in the Journal of the American Medical Association, found that immunocompromised people’s immune response contrasts to the nearly 100% antibody development among the general population by the 20th day after vaccination. | The research, published in the Journal of the American Medical Association, found that immunocompromised people’s immune response contrasts to the nearly 100% antibody development among the general population by the 20th day after vaccination. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |